Patterson Sandra 4
4 · GILEAD SCIENCES, INC. · Filed Aug 12, 2024
Insider Transaction Report
Form 4
Patterson Sandra
SVP, Controllership
Transactions
- Tax Payment
Common Stock
2024-08-10$73.66/sh−980$72,187→ 35,976 total - Exercise/Conversion
Common Stock
2024-08-10+3,678→ 36,956 total - Exercise/Conversion
Restricted Stock Unit
2024-08-10−3,678→ 14,084 total→ Common Stock (3,678 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a three year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested.